Skip to content
10-K

Annual Report

KODIAK SCIENCES INC. KOD

0000950170-25-046098

← back to feed
Filed
Mar 27, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 28, 2025 52.75M sh
Current Liabilities FY 2024 · Dec 31, 2023 $41.73M
Total Liabilities FY 2024 · Dec 31, 2023 $213.59M
Current Assets FY 2024 · Dec 31, 2023 $289.31M
Total Assets FY 2024 · Dec 31, 2023 $479.37M
Shares Diluted FY 2024 · Dec 31, 2022 52.25M sh
Capex FY 2024 · Dec 31, 2022 $37.02M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$206.46M
Cash And Equivalents FY 2024 · Dec 31, 2022 $190.43M
Eps Diluted FY 2024 · Dec 31, 2022 −$6.39
Eps Basic FY 2024 · Dec 31, 2022 −$6.39
Sga Expense FY 2024 · Dec 31, 2022 $73.79M
Rd Expense FY 2024 · Dec 31, 2022 $267.59M
Net Income FY 2024 · Dec 31, 2022 −$333.82M
Operating Income FY 2024 · Dec 31, 2022 −$341.38M
Stockholders Equity FY 2024 · Dec 31, 2021 $663.32M